Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Enhancing your stock market returns requires strategic approaches. Learn effective ways to boost your profits and investment success.
27,848 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
An executive at Fresh Del Monte sold 2,622 shares. This article explains what that means for investors, how to read i...
Caterpillar's backlog hits a record, fueling optimism that shares could approach $1,000 by 2027. Analysts weigh upsid...
A high-conviction bet on a Chinese logistics platform faced a sharp stock drop. This article explains why the fund wa...
Two AI-driven stocks with durable moats and solid cash flow could deliver outperformance over the next five years. Ex...
Nearly one-third of IRA rollovers sit in cash for seven years, draining retirement potential. Vanguard data shows man...
Despite a chorus of buy ratings on Shopify, a dissenting view flags limited upside as AI tools and monetization effor...
If you’ve got $1,000 to invest, you don’t need to chase the hottest hype. Here are three durable stocks that recently...
When top tech names dip after a sell-off, history says time these moments can unlock long-term gains. This guide brea...
Markets can stay calm even when prices rise, but two hidden forces often lurk beneath the surface. This guide identif...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
Beasley (BBGI) has a unique mix of local radio and digital assets. This guide breaks down what to watch in the 2025 e...